Skip to main content

Table 2 Age- and gender- specific standard mortality ratios and mortality of Waldenström macroglobulinemia

From: Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study

Age (years)

Total

 

Male

 

Female

 

O

E

SMR (95% CI)

O

E

SMR (95% CI)

O

E

SMR (95% CI)

 20–49

1

0.18

5.46 (0.27–26.93)

1

0.15

6.47 (0.32–31.91)

0

0.04

0.00 (−)

 50–59

8

1.14

7.03 (3.27–13.35)

5

1.21

4.12 (1.51–9.13)

3

0.16

18.32 (4.66–49.87)

 60–69

39

4.34

8.99 (6.48–12.17)

29

5.10

5.69 (3.88–8.06)

10

0.50

20.02 (10.17–35.68)

 70–79

75

13.92

5.39 (4.27–6.72)

60

15.85

3.78 (2.91–4.84)

15

1.88

7.97 (4.63–12.85)

  > 80

94

9.11

10.32 (8.39–12.57)

74

8.09

9.14 (7.23–11.41)

20

2.22

9.03 (5.67–13.69)

Total

217

28.68

7.57 (6.56–8.57)

169

30.41

5.56 (4.72–6.39)

48

4.80

9.99 (7.16–12.82)

  1. O number of observed deaths, E number of expected deaths, SMR standard mortality ratio, CI confidence interval